CN Patent

CN101980704A — 选择性s1p1受体激动剂的给药方案

Assigned to Actelion Pharmaceuticals Ltd · Expires 2011-02-23 · 15y expired

What this patent protects

本发明涉及一种选择性S1P 1 受体激动剂的给药方案，其以下述方式将选择性S1P 1 受体激动剂施用至个体：在初始治疗期期间，以诱导心脏脱敏的剂量(该剂量低于目标剂量)及维持心脏脱敏的给药频率施用该选择性S1P 1 受体激动剂，直至不再发生急性心率降低，随后上调滴定剂量，至该选择性S1P 1 受体激动剂的目标剂量。

USPTO Abstract

本发明涉及一种选择性S1P 1 受体激动剂的给药方案，其以下述方式将选择性S1P 1 受体激动剂施用至个体：在初始治疗期期间，以诱导心脏脱敏的剂量(该剂量低于目标剂量)及维持心脏脱敏的给药频率施用该选择性S1P 1 受体激动剂，直至不再发生急性心率降低，随后上调滴定剂量，至该选择性S1P 1 受体激动剂的目标剂量。

Drugs covered by this patent

Patent Metadata

Patent number
CN101980704A
Jurisdiction
CN
Classification
—
Expires
2011-02-23
Drug substance claim
No
Drug product claim
No
Assignee
Actelion Pharmaceuticals Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.